LUCA Science

About:

LUCA Science develops innovative treatments intended for mitochondrial and related diseases.

Website: https://luca-science.com/

Top Investors: SMBC Venture Capital, Nissay Capital, QB Capital, Nippon Venture Capital, DCI Partners

Description:

LUCA Science is at the forefront of a new kind of mitochondrial therapy that aims to restore cellular bioenergetics in malfunctioning or damaged tissues and organs. Using our patented iMIT technology, LUCA Science is creating a novel platform of highly functional mitochondria. We could boost bioenergetics and restore normal activities by supplying intact and functional mitochondria to the affected tissues. The utilization of mitochondria as a biopharmaceutical agent would be groundbreaking for treating a wide range of unmet medical needs.